KINIKSA PHARMACEUTICALS INTE

KNSANASDAQ

🏆 #1150 by market capEarnings Oct 26US Equity

$77.75▼ $0.08 (−0.10%)

Live

1h▼ 0.1%

24h▼ 0.1%

7d—

14d—

30d—

1y—

🏦Market Cap

$6.07B

Small Cap

📈Revenue Growth (YoY)

+58.9%

High Growth

📊Gross Margin

89.8%

High

💵FCF Margin

21.7%

Strong

⚖️P/S Ratio

7.1x

Fair

Otter Score

45

Weak

🔭

No analyst ratings for KNSA

We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.